Healthcare Sales & Marketing Network News: analgesia

Searching News Database: analgesia

HSMN NewsFeed - 24 Feb 2025
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense(TM) Cryoablation System in Israel
Devices Oncology Regulatory

HSMN NewsFeed - 29 Oct 2024
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 23 Mar 2023
New evidence demonstrates Smith & Nephew's COBLATION(TM) Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
Devices Surgery

HSMN NewsFeed - 8 Feb 2023
CoolHealth Enters U.S. Market With TargetCool(TM), A Breakthrough FDA-Class II Medical Device Offering Unprecedented Precise, Rapid Cooling For Pain Management And Bruise Minimization
Devices Dermatology Product Launch

HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Mar 2022
Heron Therapeutics Announces Approval of ZYNRELEF(R) by Health Canada for the Management of Postoperative Pain
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 29 Jul 2021
BD to Begin Remediation for BD Alaris(TM) System Software
Devices Product Recall

HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Apr 2021
BD Announces FDA 510(k) Submission for BD Alaris(TM) System
Devices FDA

HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Sep 2020
Orfadin(R) (nitisinone) receives positive opinion from CHMP for treatment of AKU
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Devices Monitoring

HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Feb 2020
Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
Biopharmaceuticals Drug Delivery Dermatology

HSMN NewsFeed - 18 Jul 2018
PainReform Gets FDA Approval for Phase III Post-Operative Pain Relief Study
Biopharmaceuticals Surgery FDA

HSMN NewsFeed - 27 Jun 2018
AcelRx receives European Commission approval for DZUVEO(TM)
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 27 Apr 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Biopharmaceutical Drug Delivery Regulatory

HSMN NewsFeed - 22 Mar 2018
Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron(TM) 1Xi Minute Ventilation Monitor in Pediatric Patients
Devices FDA

HSMN NewsFeed - 4 Jan 2018
Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS(R) for the Management of Post-operative Nausea & Vomiting
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 1 Aug 2017
AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 7 Apr 2017
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2017
AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
Devices Orthopaedic Distribution

HSMN NewsFeed - 12 Sep 2016
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jun 2016
Philips Proprietary Camera Based Monitoring Technology is First in the World to Measure Absolute Arterial Blood Oxygenation (SpO2) Levels Without Ever Touching the Patient
Devices Monitoring

HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Biopharmaceuticals Product Launch

HSMN NewsFeed - 21 Jan 2016
AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 8 Jan 2016
AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso(TM) in 1Q 2016
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Nov 2015
OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 1 Oct 2015
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2015
OticPharma Announces Key Additions to the Senior Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 21 Sep 2015
ETView and The University of Texas MD Anderson Cancer Center (Houston, TX) Announce the Start of a Prospective, Randomized Clinical Evaluation of VivaSight-DL(TM) vs. Standard Double-Lumen Endotracheal Tubes
Devices

HSMN NewsFeed - 24 Jul 2015
AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 2 Jul 2015
Zalviso(TM) Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 1 Apr 2015
Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Biopharmaceuticals

HSMN NewsFeed - 24 Feb 2015
ETView Reports on Clinical Evaluation of VivaSight(TM)
Devices

HSMN NewsFeed - 26 Sep 2014
AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jun 2014
Spacelabs Signs Global Distribution Agreement for Analgesia Pain Monitor
Devices Monitoring Distribution

HSMN NewsFeed - 12 Jun 2014
SoluMatrix(R) Meloxicam Demonstrates Significant Efficacy at 30 Percent Lower Doses in the Treatment of Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 25 Mar 2014
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2014
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch

HSMN NewsFeed - 2 Jan 2014
Smiths Medical Receives FDA 510(k) Clearance on Innovative Solution for Pain Management with CADD(R)-Solis Infusion Pump
Devices Drug Delivery FDA

HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2013
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Dec 2013
AcelRx Pharmaceuticals Adds New Board Member
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2013
Defibrotide Granted Orphan Drug Status in Australia
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Sep 2013
ETView Medical, Ltd., and Gil Medical, Ltd., (Gil Medical) Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 4 Sep 2013
David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2013
ETView Medical, Ltd., and MEDITRADE al. s ro, (MEDITRADE) Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 10 Jun 2013
ETView Medical, Ltd. and Clinical Technologies, Inc. (CTI) Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 29 May 2013
Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block for Total Knee Arthroplasty
Biopharmaceuticals

HSMN NewsFeed - 16 May 2013
New Clinical Study Finds Masimo rainbow(R) Acoustic Monitoring(TM) Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients
Devices Monitoring

HSMN NewsFeed - 6 May 2013
ETView Medical, Ltd. and Mercury Medical, Inc. (Mercury) Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 30 Apr 2013
ETView Medical, Ltd. Announces US FDA Clearance of a 510(k) Pre-marketing Notification Application Expanding the VivaSight(TM)-DL line of Innovative Airway Devices
Devices FDA

HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 6 Feb 2013
Smiths Medical Receives FDA Clearance for CADD-Solis VIP Ambulatory Infusion System
Devices FDA

HSMN NewsFeed - 14 Dec 2012
AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab(R) PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring

HSMN NewsFeed - 6 Nov 2012
Skagit Valley Hospital Standardizes on Masimo SET(R) Measure-Through Motion and Low Perfusion Pulse Oximetry
Devices Monitoring

HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 27 Aug 2012
FDA Approves Mallinckrodt’s EXALGO(R) (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Aug 2012
Spacelabs Healthcare Receives 510(k) Clearance for Sidestream Capnography Module
Devices Monitoring FDA

HSMN NewsFeed - 9 Aug 2012
Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
Biopharmaceuticals Generics Oncology

HSMN NewsFeed - 7 Aug 2012
Masimo's Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery
Devices Monitoring Cardiology Surgery

HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jun 2012
ETView Medical, Ltd. Announced CE Clearance for the VivaSight(TM)-DL line of Innovative Airway Devices
Devices Regulatory

HSMN NewsFeed - 11 Jun 2012
United Kingdom's National Health Service Includes Masimo Pleth Variability Index(R) as "High Impact Innovation" for Intra Operative Fluid Management
Devices Monitoring Surgery

HSMN NewsFeed - 4 Jun 2012
AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 May 2012
ETView Medical, Ltd. Announces US FDA Clearance of a 510(k) Pre-Marketing Notification Application for the VivaSight(TM)-DL line of Innovative Airway Devices
Devices FDA

HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Feb 2012
Pliaglis(R) Regulatory Update
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2012
ETView Medical, Ltd., and NeuroMed Ltd. (NeuroMed), Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 22 Dec 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms
Biopharmaceuticals

HSMN NewsFeed - 31 Oct 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 27 Jan 2011
Newly Published Data Demonstrates Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
Biopharmaceuticals Pain Management Surgery

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2010
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Jun 2010
Masimo Initiates Full Market Release of Rainbow Acoustic Monitoring
Devices Monitoring

HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 6 Apr 2010
AcelRx Pharmaceuticals Names Richard King Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2010
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
Biopharmaceuticals FDA Mergers & Acquisitions

HSMN NewsFeed - 19 Jan 2010
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2009
Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Dec 2009
Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring
Devices Monitoring FDA

HSMN NewsFeed - 20 Nov 2009
FDA Extends Review of NDA for Exalgo
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 14 Oct 2009
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Aug 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Biopharmaceuticals Drug Delivery Surgery

HSMN NewsFeed - 31 Jul 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jun 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals

HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management

HSMN NewsFeed - 16 Mar 2009
New Clinical Study Finds Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Accurate in the Noninvasive Monitoring of Fluid Status During Surgery
Devices Monitoring

HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
Biopharmaceuticals

HSMN NewsFeed - 26 Jan 2009
Targin(R) (Oral Oxycodone/Naloxone Prolonged-Release Tablet) now Launching Across Europe to Control Severe Chronic Pain With Significantly Reduced Risk of Opioid-Induced Constipation
Biopharmaceuticals

HSMN NewsFeed - 16 Dec 2008
Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 9 Dec 2008
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Biopharmaceuticals Pain Management

HSMN NewsFeed - 20 Nov 2008
MINRAD International, Inc. Announces Reduction in Workforce
Devices

HSMN NewsFeed - 19 Aug 2008
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
Biopharmaceuticals

HSMN NewsFeed - 14 Jul 2008
New Publication Shows Cleviprex(TM) is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Jun 2008
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2008
Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2008
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2008
Anesiva Announces Expansion of Zingo Agreement in Europe
Biopharmaceuticals Distribution Licensing

HSMN NewsFeed - 8 Apr 2008
Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
Biopharmaceuticals

HSMN NewsFeed - 3 Apr 2008
Masimo PVI(TM) Cleared for Market in Japan
Devices Monitoring Regulatory

HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Mar 2008
MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution

HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Feb 2008
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2008
Sosei Announces Start of AD 923 Phase III Studies in Europe
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Feb 2008
Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries
Biopharmaceuticals Drug Delivery Distribution Licensing

HSMN NewsFeed - 30 Jan 2008
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Jan 2008
MicroIslet Announces the Appointments of Dr. Chris Marsh as Lead Transplant Advisor, and Dr. Ronald Goldblum as Lead Clinical Development Consultant
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management

HSMN NewsFeed - 19 Dec 2007
Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 14 Dec 2007
Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2007
Javelin Pharmaceuticals Launches Dyloject(R) in UK
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2007
Remoxy Meets Primary Endpoint in Pivotal Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2007
Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2007
Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 15 Nov 2007
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2007
More Than 20 New Studies Show the Many Benefits of Essure(R) Compared with Surgical Tubal Ligation
Devices

HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Oct 2007
Wright Medical Acquires Innovative BIO-ARCH(TM) Foot and Ankle Implant from Metasurg
Devices Orthopaedic Acquisitions

HSMN NewsFeed - 17 Oct 2007
Innocoll Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
Biopharmaceuticals Wound Care

HSMN NewsFeed - 16 Oct 2007
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Biopharmaceuticals Drug Delivery Pain Management

HSMN NewsFeed - 15 Oct 2007
Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
Devices Monitoring

HSMN NewsFeed - 12 Oct 2007
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Biopharmaceuticals Drug Delivery Pain Management

HSMN NewsFeed - 11 Oct 2007
Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Oct 2007
Anesiva Defines Regulatory Pathway for Adlea with FDA
Biopharmaceuticals Surgery

HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Pain Management Surgery

HSMN NewsFeed - 26 Sep 2007
New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
Biopharmaceuticals Pain Management

HSMN NewsFeed - 10 Sep 2007
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 6 Sep 2007
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Biopharmaceuticals Surgery Acquisitions

HSMN NewsFeed - 17 Aug 2007
MINRAD International, Inc. Announces Appointment of Dennis Goupil, PhD, as Senior Vice President Technical and Terence Vollrath as Vice President Operations
Devices Personnel

HSMN NewsFeed - 17 Aug 2007
Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 2 Aug 2007
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
Devices Drug Delivery Personnel

HSMN NewsFeed - 27 Jun 2007
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 7 Jun 2007
Iroko Pharmaceuticals Appoints Susan F. Langer M.D. as Chief Medical Officer and Vice President of Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 May 2007
MINRAD International, Inc. Announces FDA Approval of Sojourn(TM) Sevoflurane
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2007
FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
Biopharmaceuticals FDA

HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 13 Apr 2007
I-Flow Announces ON-Q Study Concluded at World-Renowned Miami Children's Hospital, Results Presented at the 2007 Pediatric Anesthesiology Meeting
Devices

HSMN NewsFeed - 4 Apr 2007
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery

HSMN NewsFeed - 29 Mar 2007
Innocoll Files US and Irish Patent Applications for its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery

HSMN NewsFeed - 28 Mar 2007
Anesiva Commences Phase 3 Clinical Study of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Biopharmaceuticals

HSMN NewsFeed - 26 Mar 2007
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 20 Mar 2007
MINRAD International, Inc. Announces Japanese Approval of Sevoflurane
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 26 Feb 2007
King Pharmaceuticals Completes Strategic Acquisition of AVINZA(R)
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel

HSMN NewsFeed - 14 Feb 2007
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine Study
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2007
Anesiva Announces FDA Acceptance for Filing of Zingo(TM) New Drug Application to Reduce Pain Associated With Needle Insertion Procedures in Children
Biopharmaceuticals

HSMN NewsFeed - 6 Feb 2007
Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k)
Devices FDA

HSMN NewsFeed - 30 Jan 2007
Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 29 Jan 2007
DURECT Signs POSIDUR(TM) Manufacturing Agreement with Hospira
Biopharmaceuticals

HSMN NewsFeed - 19 Jan 2007
Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2007
XTL Biopharmaceuticals Announces the In-Licensing of Bicifadine - A Late-Stage Clinical Compound for the Treatment of Neuropathic Pain
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Dec 2006
I-Flow Announces ON-Q Therapy Upheld as Best Practice for Post-Surgical Pain Relief in Pivotal Study
Devices Surgery

HSMN NewsFeed - 13 Dec 2006
Pain Therapeutics Initiates Phase III Study With Oxytrex(TM)
Biopharmaceuticals

HSMN NewsFeed - 29 Nov 2006
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR(TM) in Europe and Other Select Countries
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2006
Anesiva Announces Filing of New Drug Application for Zingo(TM) to Reduce Pain Associated with Needle Insertion Procedures in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2006
Hospira Unveils Symbiq(TM) Next-Generation Infusion System
Devices

HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
Hospira Announces $2 Billion Agreement to Acquire Mayne Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Sep 2006
Hospira Announces New Contract With HealthTrust to Provide Pain Management Infusion Pumps to Members
Devices Group Purchasing

HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 23 May 2006
Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM)
Biopharmaceuticals

Return to NewsFeed

Additional items found! 114

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 114 additional stories matching:
analgesia
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.